Skip to main content

IG 272 2.5mg Pill - orange capsule/oblong, 4mm

Pill with imprint IG 272 2.5mg is Orange, Capsule/Oblong and has been identified as Ramipril 2.5 mg. It is supplied by InvaGen Pharmaceuticals, Inc.

Ramipril is used in the treatment of High Blood Pressure; Left Ventricular Dysfunction; Diabetic Kidney Disease; Heart Attack; Cardiovascular Risk Reduction and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IG 272 2.5mg

Ramipril 2.5 mg IG 272 2.5mg
Ramipril 2.5 mg IG 272 2.5mg

Ramipril

Imprint
IG 272 2.5mg
Strength
2.5 mg
Color
Orange
Size
4.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
InvaGen Pharmaceuticals, Inc.
National Drug Code (NDC)
67787-0272

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.